Financials data is unavailable for this security.
View more
Year on year Cell MedX Corp had revenues fall -100.00% from 2.76k to 0.00, though the company grew net income from a loss of 495.04k to a smaller loss of 142.49k.
Gross margin | -- |
---|---|
Net profit margin | -- |
Operating margin | -- |
Return on assets | -190.76% |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in USDView more
In 2024, cash reserves at Cell MedX Corp fell by 54.88k. Cash Flow from Financing totalled 91.03k or -- of revenues. In addition the company used 145.90k for operations while cash used for investing totalled .
Cash flow per share | -0.0009 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.0028 |
---|---|
Tangible book value per share | -0.0028 |
More ▼
Balance sheet in USDView more
Current ratio | 0.0529 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼